In conclusion, more studies are needed to unravel whether PXR plays a role in the development and the progression of NAFLD/NASH and to understand the timing of its function in the different stages of this complex disease. The gene discussed is NR1I2; the disease is metabolic dysfunction-associated steatohepatitis.